News Column

CELLECTAR BIOSCIENCES, INC. FILES (8-K) Disclosing Regulation FD Disclosure, Financial Statements and Exhibits

August 20, 2014



ITEM 7.01 REGULATION FD DISCLOSURE

On August 14, 2014, we issued a press release announcing that we had priced our underwritten public offering of 3,333,333 shares of common stock at a per share price of $3.75 and warrants to purchase up to the same number of shares of common stock at a per warrant price of $0.01; plus the issuance of approximately an additional 1,110,000 shares and warrants in consideration of the cancellation of $4,000,000 principal amount of convertible debentures plus accrued interest. Both our common stock and the warrants issued in conjunction with this offering will be listed on the NASDAQ Capital Market under the symbols "CLRB" and "CLRBW," respectively. A copy of the press release is furnished as Exhibit 99.1 and is incorporated by reference herein.

2



ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits Number Title 99.1 Press release dated August 14, 2014, entitled "Cellectar Biosciences Announces Pricing of $12,500,000 Public Offering and Listing on The Nasdaq Capital Market" 3


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Edgar Glimpses


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters